Biointron delivers advanced bispecific antibody production with over 260 proven formats, offering rapid expression, scalable solutions, and trusted CRO expertise for therapeutic development.
Automation transforms antibody workflows. Discover robotic systems and integrated platforms that raise throughput, consistency, and data confidence.
Understand affinity maturation from natural immune processes to Biointron’s FCMES-AM™ platform, enhancing antibody affinity, specificity, and therapeutic performance.
Discover how hybridoma sequencing prevents cell line loss, ensures accurate antibody sequences, and enables recombinant expression for consistent, scalable antibody production.
High-throughput antibody production changes the pace of biotech. Learn how automation and Single B Cell Screening deliver thousands of antibodies with speed and quality.
The alpaca advantage: VHH discovery powered by unique immune repertoires. See how Biointron leverages alpaca libraries for robust nanobody identification.
You can also contact us on the Scientist and Science Exchange marketplaces.
Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.
Biointron uses cookies and similar technologies to ensure proper website functionality, understand how visitors use our website, and improve our content and services. Necessary cookies are enabled by default.
By clicking “Accept All”, you agree to the use of all cookies, including analytics and optional cookies that help us understand website usage and improve user experience. By clicking “Reject Non-Essential”, only necessary cookies will be used.
You may manage or change your cookie preferences at any time by clicking “Cookie Settings” at the bottom of the website.
For more information about how we use cookies and process personal data, please review our Privacy Policy.
